Michael Jewett

578 total citations
22 papers, 397 citations indexed

About

Michael Jewett is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Michael Jewett has authored 22 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pulmonary and Respiratory Medicine, 10 papers in Surgery and 8 papers in Molecular Biology. Recurrent topics in Michael Jewett's work include Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Renal and related cancers (5 papers). Michael Jewett is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Renal cell carcinoma treatment (7 papers) and Renal and related cancers (5 papers). Michael Jewett collaborates with scholars based in Canada, United States and Palestinian Territory. Michael Jewett's co-authors include Neil Fleshner, Yair Lotan, Joseph L. Chin, Martin Gleave, Jeremy P.W. Heaton, Larry Goldenberg, Laurence Klotz, Andrew Evans, Theodorus van der Kwast and Alexandre R. Zlotta and has published in prestigious journals such as Journal of Clinical Oncology, Cancer and Cancer Research.

In The Last Decade

Michael Jewett

22 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Jewett Canada 9 217 187 118 94 46 22 397
Francesc Vigués Spain 11 200 0.9× 155 0.8× 239 2.0× 93 1.0× 49 1.1× 45 511
Ioannis Zachos Greece 11 153 0.7× 137 0.7× 55 0.5× 43 0.5× 30 0.7× 43 302
Gianfranco Mattarelli Switzerland 7 121 0.6× 106 0.6× 69 0.6× 34 0.4× 26 0.6× 10 272
C. Bastide France 10 89 0.4× 240 1.3× 39 0.3× 56 0.6× 55 1.2× 57 347
Ahmed Aboumohamed United States 10 220 1.0× 151 0.8× 65 0.6× 42 0.4× 113 2.5× 32 392
Wagner Eduardo Matheus Brazil 13 134 0.6× 214 1.1× 35 0.3× 35 0.4× 83 1.8× 41 361
Jacques Irani France 8 75 0.3× 216 1.2× 62 0.5× 39 0.4× 34 0.7× 12 338
A. Thanos Greece 9 102 0.5× 80 0.4× 67 0.6× 65 0.7× 67 1.5× 26 303
E. Bromwich United Kingdom 5 66 0.3× 213 1.1× 125 1.1× 151 1.6× 9 0.2× 7 330
L Mosca Italy 13 108 0.5× 35 0.2× 34 0.3× 120 1.3× 6 0.1× 30 497

Countries citing papers authored by Michael Jewett

Since Specialization
Citations

This map shows the geographic impact of Michael Jewett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Jewett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Jewett more than expected).

Fields of papers citing papers by Michael Jewett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Jewett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Jewett. The network helps show where Michael Jewett may publish in the future.

Co-authorship network of co-authors of Michael Jewett

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Jewett. A scholar is included among the top collaborators of Michael Jewett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Jewett. Michael Jewett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lilge, Lothar, Arkady Mandel, Nathan Perlis, et al.. (2019). TLD-1433 photodynamic therapy for BCG-unresponsive NMIBC: a Phase IB clinical study (Conference Presentation). 51–51. 2 indexed citations
2.
Matthew, A., Daniel Santa Mina, Neil Fleshner, et al.. (2018). The Prostate Cancer Rehabilitation Clinic: A Biopsychosocial Clinic for Sexual Dysfunction after Radical Prostatectomy. Current Oncology. 25(6). 393–402. 18 indexed citations
3.
Tanguay, Simon, Anil Kapoor, Michael Jewett, et al.. (2018). Use of Targeted Therapy in Patients with Metastatic Renal Cell Carcinoma: Clinical and Economic Impact in a Canadian Real-Life Setting. Current Oncology. 25(6). 576–584. 17 indexed citations
4.
Patel, Premal, Jasmir G. Nayak, Zhihui Liu, et al.. (2017). A Multicentered, Propensity Matched Analysis Comparing Laparoscopic and Open Surgery for pT3a Renal Cell Carcinoma. Journal of Endourology. 31(7). 645–650. 9 indexed citations
5.
Forbes, Connor M., Ricardo Rendon, Antonio Finelli, et al.. (2016). Disease progression and kidney function after partial vs. radical nephrectomy for T1 renal cancer. Urologic Oncology Seminars and Original Investigations. 34(11). 486.e17–486.e23. 31 indexed citations
6.
Kulkarni, Girish S., et al.. (2015). MP86-16 FATE OF PROSTATE CANCER ANTIGEN 3 (PCA3) LEVELS MORE THAN 100: DOES INFLAMMATION PLAY A ROLE??. The Journal of Urology. 193(4S). 1 indexed citations
7.
Jewett, Michael, Joan Basiuk, Christopher Morash, et al.. (2014). Growth kinetics of small renal masses: A prospective analysis from the Renal Cell Carcinoma Consortium of Canada. Canadian Urological Association Journal. 8(1-2). 24–24. 34 indexed citations
8.
9.
Jewett, Michael, Mohamed Abdolell, Neil Fleshner, et al.. (2013). 1182 GROWTH KINETICS OF SMALL RENAL MASSES: A PROSPECTIVE ANALYSIS FROM THE RENAL CELL CARCINOMA CONSORTIUM OF CANADA. The Journal of Urology. 189(4S). 1 indexed citations
10.
Joshua, Anthony M., Neil Fleshner, Michaël Pollak, et al.. (2012). Abstract A15: A phase 2 study of neoadjuvant metformin in prostatic carcinoma. Cancer Research. 72(4_Supplement). A15–A15. 1 indexed citations
11.
Joshua, Anthony M., Vanessa E. Zannella, Marianne Koritzinsky, et al.. (2012). Abstract CT-04: A phase II study of neoadjuvant metformin in prostatic carcinoma. Cancer Research. 72(8_Supplement). CT–4. 2 indexed citations
12.
Mir, Carmen, Shahrokh F. Shariat, Theodorus van der Kwast, et al.. (2010). Loss of androgen receptor expression is not associated with pathological stage, grade, gender or outcome in bladder cancer: a large multi‐institutional study. British Journal of Urology. 108(1). 24–30. 108 indexed citations
13.
Leveridge, Michael, Daniel Shiff, Hannah Chung, et al.. (2010). 821 SMALL RENAL MASS NEEDLE CORE BIOPSY: OUTCOMES OF NON-DIAGNOSTIC PERCUTANEOUS BIOPSY AND ROLE OF REPEAT BIOPSY. The Journal of Urology. 183(4S). 3 indexed citations
14.
Lotan, Yair, Ashish M. Kamat, Michael P. Porter, et al.. (2009). Key concerns about the current state of bladder cancer. Cancer. 115(18). 4096–4103. 52 indexed citations
15.
Finelli, Antonio, Sanoj Punnen, Tara Rosewall, et al.. (2009). Transperitoneal Laparoscopic Prostatectomy Does Not Increase Small Bowel Within the Target Volume for Postoperative Radiotherapy. The Journal of Urology. 182(5). 2280–2284. 2 indexed citations
16.
Kwast, Theodorus van der, Alexandre R. Zlotta, Neil Fleshner, et al.. (2008). Thirty-five years of noninvasive bladder carcinoma: a plea for the use of papillary intraurothelial neoplasia as new terminology.. PubMed. 30(6). 309–15. 5 indexed citations
17.
Broom, Reuben, et al.. (2008). Rationale and evidence for the use of sunitnib to treat patients with malignant paraganglioma/pheochromocytoma (MPP). Journal of Clinical Oncology. 26(15_suppl). 14681–14681. 1 indexed citations
18.
Trachtenberg, John, Ants Toi, Joan Sweet, et al.. (2003). A phase I trial of adenovector-mediated delivery of interleukin-2 (AdIL-2) in high-risk localized prostate cancer. Cancer Gene Therapy. 10(10). 755–763. 47 indexed citations
19.
Klotz, Laurence, Jeremy P.W. Heaton, Michael Jewett, et al.. (2000). A RANDOMIZED PHASE 3 STUDY OF INTRAOPERATIVE CAVERNOUS NERVE STIMULATION WITH PENILE TUMESCENCE MONITORING TO IMPROVE NERVE SPARING DURING RADICAL PROSTATECTOMY. The Journal of Urology. 1573–1578. 3 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Francesc Vigués Breakdown of academic impact, for papers by Ioannis Zachos Breakdown of academic impact, for papers by Gianfranco Mattarelli Breakdown of academic impact, for papers by C. Bastide Breakdown of academic impact, for papers by Ahmed Aboumohamed Breakdown of academic impact, for papers by Wagner Eduardo Matheus Breakdown of academic impact, for papers by Jacques Irani Breakdown of academic impact, for papers by A. Thanos Breakdown of academic impact, for papers by E. Bromwich Breakdown of academic impact, for papers by L Mosca
Rankless by CCL
2026